ALZFORUM3d
Donanemab Clinical Use Growing in U.S., Rejected in Europe
Like lecanemab before it, donanemab’s path to market has been slow and rocky. In the U.S., the antibody received Food and ...
ALZFORUM5d
Filling in the Family Tree—AD, CTE Folds Spotted in Other Tauopathies
Dysfunctional Family. A family tree of tau folds now incorporates two new structures—P301L, P301T (bottom)—and fills in ...
ALZFORUM3d
Plaque Removal Delays Onset of Familial Alzheimer’s Disease
The first evidence that removing amyloid plaques may delay Alzheimer’s symptoms has now been published. In The Lancet Neurology on March 19, scientists led by Randall Bateman at Washington University ...
ALZFORUM12d
Eat Well, Stay Trim—Your Brain Will Thank You Later
Having a better midlife diet associated with better functional connectivity between the hippocampus and both the occipital ...
ALZFORUM11d
Is Dementia Incidence Still Dropping? Birth Cohort Data Say Yes.
As the baby boom generation reaches its hopefully golden years, scientists have been projecting a doubling of dementia cases in the U.S. by 2050, alarming health care agencies, the public, and health ...
ALZFORUM13d
ALS or Alzheimer’s? Blood Phospho-Tau Could Mean Either
For years, the Alzheimer’s disease field has been on a quest for the perfect blood marker. Such a test could spare patients from invasive lumbar punctures, broaden care access, and allow AD cases to ...
ALZFORUM10d
Member Directory
University Hospital Leipzig and Max Planck Institute for Human Cognitive and Brain Sciences ...
ALZFORUM10d
Mobile Devices Track Brain Health in 23,000 People
Cognitive slippage is a normal part of aging, but what distinguishes this inevitable slowdown from the type of decline that foreshadows neurodegenerative disease? And might remote, digital ...